Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FK97X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,874
Award facts
- Contract value 100% obligated
- $72,873.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on October 20, 2025, provides for the supply of Menveo vaccine (meningococcal conjugate vaccine A-C-Y-W-135) in single-dose vials to support federal medical supply needs. The contract is valued at $72,873.70 under a firm fixed-price arrangement with an ultimate completion date of October 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor. The Defense Logistics Agency, which manages the federal medical supply chain for military and veteran healthcare systems, is the funding agency. This award is not designated as a set-aside contract, indicating it was competitively awarded through open procurement processes.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The Menveo vaccine delivery supports the federal government's vaccination and immunization programs across the military and related healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FK97X?
SPE2DB26FK97X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FK97X worth?
The government has obligated $72,874 on SPE2DB26FK97X.
Is contract SPE2DB26FK97X an order under another contract?
Yes. SPE2DB26FK97X is a delivery order under SPE2DB20D2002, an indefinite delivery contract.
Was contract SPE2DB26FK97X competed?
The extent of competition for SPE2DB26FK97X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award